SARS-CoV2 Infection and Comorbidity in Inmates: A Study of Central Italy
-
Published:2023-02-09
Issue:4
Volume:20
Page:3079
-
ISSN:1660-4601
-
Container-title:International Journal of Environmental Research and Public Health
-
language:en
-
Short-container-title:IJERPH
Author:
Altobelli Emma1, Galassi Francesca1, Mastrodomenico Marianna2, Frabotta Fausto2, Marzi Francesca3, Angelone Anna Maria1, Marziliano Ciro4ORCID
Affiliation:
1. Department of Life, Public Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy 2. Public Health Unit, Avezzano-Sulmona-L’Aquila, 67100 L’Aquila, Italy 3. Department of Information Engineering, Computer Science and Mathematics University of L’Aquila, 67100 L’Aquila, Italy 4. Statistical Observatory and Indicator Monitoring, University of L’Aquila, 67100 L’Aquila, Italy
Abstract
Background and Objective: The presence of multiple chronic diseases is associated with an increase in mortality when related to COVID-19 infection. The aims of our study were: (i) to evaluate the association between the severity of the COVID-19 disease, defined as symptomatic hospitalized in prison or symptomatic hospitalized out of prison, and the presence of one or more comorbidities in two prisons in central Italy: L’Aquila and Sulmona; (ii) to describe the profiles of inmates using multiple correspondence analysis (MCA). Methods: A database was created including age, gender and clinical variables. The database containing anonymized data was password-protected. The Kruskal–Wallis test was used to evaluate a possible association between diseases and the severity of COVID-19 stratified by age groups. We used MCA to describe a possible characteristic profile of inmates. Results: Our results show that in the 25–50-year-old age group (COVID-19-negative) in the L’Aquila prison, 19/62 (30.65%) were without comorbidity, 17/62 (27.42%) had 1–2 comorbidities and only 3.23% had >2 diseases. It is interesting to note that in the elderly group, the frequency of 1–2 or >2 pathologies was higher than in the younger group, and only 3/51 (5.88%) inmates did not have comorbidities and were COVID-19 negative (p = 0.008). The MCA identified the following profiles: the prison of L’Aquila showed a group of women over 60 with diabetes, cardiovascular and orthopedic problems, and hospitalized for COVID-19; the Sulmona prison presented a group of males over 60 with diabetes, cardiovascular, respiratory, urological, gastrointestinal and orthopedic problems, and hospitalized or symptomatic due to COVID-19. Conclusions: our study has demonstrated and confirmed that advanced age and the presence of concomitant pathologies have played a significant role in the severity of the disease: symptomatic hospitalized in the prison; symptomatic hospitalized out of the prison.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference29 articles.
1. Esposito, M., Salerno, M., Di Nunno, N., Ministeri, F., Liberto, A., and Sessa, F. (2022). The Risk of COVID-19 Infection in Prisons and Prevention Strategies: A Systematic Review and a New Strategic Protocol of Prevention. Healthcare, 10. 2. COVID-19 in prisons: An impossible challenge for public health?;Simas;Cad Saude Publica,2020 3. COVID-19 Incidence and Mortality in Federal and State Prisons Compared with the US Population, April 5, 2020, to April 3, 2021;Marquez;JAMA,2021 4. Altobelli, E., Marzi, F., Angelone, A.M., Mazzocca, R., Mastrodomenico, M., Petrocelli, R., and Marziliano, C. (2022). Burden of COVID-19 and Vaccination Coverage in the Italian Population as of October 2021. Int. J. Environ. Res. Public Health, 19. 5. World Health Organization (WHO) (2020). Coronavirus Disease 2019 (COVID-19) Situation Report—36, WHO. Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36-covid-19.pdf.
|
|